• Serine and Arginine-rich Splicing Factor 2 (SRSF2) Gene Mutation Analysis
  • Coagulation Factor II Activity Assay, Plasma
  • Diabetes insipidus
  • Brucellosis
  • Rheumatic heart disease
  • Clonazepam, Serum
  • Biopsy, Bile Duct
  • Pepsinogen I
  • Cancer Antigen (CA) 72-4
  • Hypoxia-Inducible Factor Alpha (EPAS1/HIF2A) Gene, Exons 9 and 12 Sequencing
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Diseases (1)
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.